Stock Mumak

Stock Profile

Moderna, Inc.

Moderna is one of the leading biotechnology companies in the field of mRNA technology. A strong research pipeline and the development of new vaccines and therapeutics offer long-term growth potential.

Stock Snapshot

Moderna_logo
Table HeaderTable Header
CompanyModerna, Inc.
SectorPharmaceuticals & Biotechnology
ThemeOncology and vaccines
Business ModelDevelopment of therapeutics and vaccines for cancer, infectious, autoimmune, and cardiovascular diseases
ISINUS60770K1079
Market Capitalizationapprox. $27.6 billion
UMBRELLA StatusWatchlist

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Latest Portfolio Updates

Tesla, Inc.
Company Update

Tesla – Q2 2026 Earnings Update

Tesla delivered record revenue and strong vehicle deliveries in Q2 2026. However, heavy investment in AI and robotics weighed on
Next Update
Johnson & Johnson
Company Update

Johnson & Johnson – Q2 2026 Earnings Update

Johnson & Johnson impresses with strong Q2 2026 figures, significantly increasing revenue and free cash flow while raising its guidance
Next Update
Weekly Update

Weekly Market Overview – July 13-19, 2026

IBM's earnings warning rattles the stock markets. Why fundamental data, quarterly results, and company outlooks are once again the most
Next Update
Weekly Update

Weekly Market Overview – June 29–July 5, 2026

The healthcare sector remains in the lead, while technology and defense stocks are regaining strength. Positive impulses for the UMBRELLA
Next Update